Bank Pictet & Cie Europe AG Acquires 6,050 Shares of Zoetis Inc. $ZTS

Bank Pictet & Cie Europe AG increased its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 1.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 398,610 shares of the company’s stock after acquiring an additional 6,050 shares during the quarter. Zoetis comprises 1.2% of Bank Pictet & Cie Europe AG’s portfolio, making the stock its 21st biggest holding. Bank Pictet & Cie Europe AG’s holdings in Zoetis were worth $58,325,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Nova Wealth Management Inc. acquired a new position in shares of Zoetis in the first quarter valued at $25,000. Halbert Hargrove Global Advisors LLC boosted its holdings in shares of Zoetis by 496.6% during the third quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock worth $25,000 after acquiring an additional 144 shares during the period. REAP Financial Group LLC increased its stake in shares of Zoetis by 201.5% during the second quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock worth $31,000 after purchasing an additional 131 shares during the period. NewSquare Capital LLC boosted its stake in Zoetis by 69.1% in the 2nd quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock valued at $32,000 after purchasing an additional 85 shares during the period. Finally, 1248 Management LLC acquired a new position in Zoetis in the 1st quarter valued at $35,000. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analyst Ratings Changes

ZTS has been the subject of a number of recent research reports. Argus reissued a “buy” rating and issued a $190.00 target price on shares of Zoetis in a research report on Tuesday, September 9th. Stifel Nicolaus cut their price objective on shares of Zoetis from $140.00 to $130.00 and set a “hold” rating for the company in a report on Tuesday, November 18th. Barclays assumed coverage on shares of Zoetis in a research report on Monday, December 8th. They set an “equal weight” rating and a $136.00 target price on the stock. The Goldman Sachs Group upgraded shares of Zoetis to a “buy” rating in a research report on Monday, December 15th. Finally, Morgan Stanley set a $160.00 price target on Zoetis in a research report on Thursday, December 18th. Six investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $160.18.

Zoetis Stock Performance

Zoetis stock opened at $125.82 on Friday. The stock has a market cap of $55.45 billion, a PE ratio of 21.18, a P/E/G ratio of 2.73 and a beta of 0.97. The company has a quick ratio of 2.28, a current ratio of 3.64 and a debt-to-equity ratio of 1.31. Zoetis Inc. has a 12-month low of $115.25 and a 12-month high of $177.40. The business’s 50-day moving average price is $125.43 and its two-hundred day moving average price is $142.01.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, beating analysts’ consensus estimates of $1.62 by $0.08. The company had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.42 billion. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The firm’s quarterly revenue was up .5% compared to the same quarter last year. During the same period last year, the company posted $1.58 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 3rd. Stockholders of record on Tuesday, January 20th will be issued a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a dividend yield of 1.7%. This is a boost from Zoetis’s previous quarterly dividend of $0.50. The ex-dividend date is Tuesday, January 20th. Zoetis’s dividend payout ratio (DPR) is currently 33.67%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.